Modified two-sided normal tolerance intervals for batch acceptance of dose uniformity

被引:11
作者
Hauck, WW [1 ]
Shaikh, R [1 ]
机构
[1] Thomas Jefferson Univ, Biostat Sect, Philadelphia, PA 19107 USA
关键词
tolerance intervals; content uniformity;
D O I
10.1002/pst.103
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We consider modified tolerance intervals for assessing content (dose) uniformity from one- and two-stage designs. This work was motivated by a proposal from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) to modify tolerance intervals to reduce their known conservatism away from the centre of the acceptance interval. IPAC-RS's original proposal suffers from anti-conservatism, but we find this is due to the choice of constants, not the form of the acceptance rule. We propose an alternative basis for choosing the constants in the acceptance rules and compare attained levels to those of other choices, including revised constants proposed by IPACRS. These alternate choices of the constants lead to modified tolerance intervals that are either conservative at the sample sizes for which they were chosen or may have slight anti-conservatism, within the limits of the simulations. Copyright (C) 2004 John Wiley Sons Ltd.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 13 条
  • [1] Hauck W W, 2001, J Biopharm Stat, V11, P335, DOI 10.1081/BIP-120008852
  • [2] Hauck W W, 1997, J Biopharm Stat, V7, P87, DOI 10.1080/10543409708835171
  • [3] *IPAC RS, 2001, PAR TOL INT TEST IMP
  • [4] KATORI N, 1997, USP PHARMACOPEIAL FO, V23, P5325
  • [5] DISCRETE SEQUENTIAL BOUNDARIES FOR CLINICAL-TRIALS
    LAN, KKG
    DEMETS, DL
    [J]. BIOMETRIKA, 1983, 70 (03) : 659 - 663
  • [6] LAN KKG, 1985, J CHINESE STAT ASS, V23, P171
  • [7] SAMPLE-SIZE DETERMINATION FOR 2-SIDED BETA-EXPECTATION TOLERANCE INTERVALS FOR A NORMAL-DISTRIBUTION
    ODEH, RE
    CHOU, YM
    OWEN, DB
    [J]. TECHNOMETRICS, 1989, 31 (04) : 461 - 468
  • [8] OLSSON B, 2003, US FDA ADV COMM PHAR
  • [9] OWEN DB, 1965, BIOMETRIKA, V52, P437, DOI 10.2307/2333696
  • [10] *PHRMA STAT WORK G, 1999, PHARMACOPEIAL FORUM, V25, P8609